BR100 Increased By (0.77%)
BR30 Increased By (0.52%)
KSE100 Increased By (0.66%)
KSE30 Increased By (0.68%)
AGHA 7.78 Increased By ▲ 0.03 (0.39%)
BECO 5.20 Increased By ▲ 0.01 (0.19%)
BML 57.59 Decreased By ▼ -1.07 (-1.82%)
BOP 34.22 Increased By ▲ 0.53 (1.57%)
CNERGY 10.77 Increased By ▲ 0.16 (1.51%)
CSIL 5.43 Increased By ▲ 0.13 (2.45%)
FCCL 54.90 Increased By ▲ 1.16 (2.16%)
FFL 16.72 Increased By ▲ 0.26 (1.58%)
FNEL 1.25 Increased By ▲ 0.03 (2.46%)
KEL 7.44 Increased By ▲ 0.16 (2.2%)
KOSM 5.85 Increased By ▲ 0.21 (3.72%)
LOTCHEM 29.74 Increased By ▲ 0.09 (0.3%)
MLCF 95.60 Decreased By ▼ -0.76 (-0.79%)
NBP 203.70 Increased By ▲ 0.17 (0.08%)
NCPL 58.00 Increased By ▲ 1.15 (2.02%)
NPL 69.30 Increased By ▲ 1.99 (2.96%)
OGDC 318.20 Decreased By ▼ -0.02 (-0.01%)
PACE 10.75 Increased By ▲ 0.12 (1.13%)
PAEL 42.90 Increased By ▲ 1.13 (2.71%)
PIBTL 16.80 Decreased By ▼ -0.01 (-0.06%)
PPL 221.23 Increased By ▲ 1.06 (0.48%)
PRL 51.51 Increased By ▲ 2.46 (5.02%)
PTC 70.80 Increased By ▲ 0.79 (1.13%)
SSGC 28.68 Decreased By ▼ -0.46 (-1.58%)
TBL 9.90 Increased By ▲ 0.13 (1.33%)
TELE 8.90 Increased By ▲ 0.08 (0.91%)
TPL 18.25 Increased By ▲ 1.08 (6.29%)
TPLP 12.96 Increased By ▲ 0.45 (3.6%)
TREET 22.70 Increased By ▲ 0.11 (0.49%)
TRG 59.92 Decreased By ▼ -0.30 (-0.5%)
By

SINGAPORE: The CBOT soybean November contract may rise into a range of $12.09-3/4 to $12.22-1/2 per bushel, following the completion of a five-wave cycle.

The cycle is expected to be partially or totally reversed. The bullish divergence on the hourly RSI confirms a completion of the cycle and suggests a further bounce.

Support is at $11.88-1/2, a break below which could signal a continuation of the downtrend towards the range of $11.71-3/4 to $11.82-1/4.

On the daily chart, the contract stabilised around a support at $11.83-1/2, the 100% projection level of a downward wave c from $14.23.

This wave could either end around $11.83-1/2 or extend far below it. Regardless of the ending point, the contract may hover above $11.83-1/2 for some time.

Each reader should consult his or her own professional or other advisers for business, financial or legal advice regarding the products mentioned in the analyses.

Comments

Comments are closed for this article.